Company · CIK 0001022079 · SIC 8071 — Services-Medical Laboratories · NYSE
QUEST DIAGNOSTICS INC · DGX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 SForm 4 → | Sep 3, 5:05 pm EDT | J. E. DavisCEO and President, Director | 10,000 | $242.72 | $2,427,200 | 122,423 | −7.55% | 10b5-1 |
| Aug 28, 2026 SForm 4 → | Aug 31, 4:37 pm EDT | Michael E PrevoznikSVP & General Counsel | 22,677 | $243.11 | $5,513,083 | 37,557 | −37.6% | 10b5-1 |
| Aug 28, 2026 GMForm 4 → | Aug 31, 4:37 pm EDT | Michael E PrevoznikSVP & General Counsel | 23,677 | $112.17 | $2,543,679 | 36,557 | — | 10b5-1 |
| Jul 28, 2026 SForm 4 → | Jul 29, 5:04 pm EDT | Mark E DelaneySVP & Chief Commercial Officer | 1,600 | $235.18 | $376,288 | 10,335 | −13.4% | 10b5-1 |
| Jul 22, 2026 LForm 4 → | Jul 27, 4:35 pm EDT | Karthik KuppusamySVP, Clinical Solutions | 37 | $206.81 | $7,652 | 13,557 | — | late |
| Jul 22, 2026 LForm 4 → | Jul 27, 4:35 pm EDT | Robert B CarterDirector | 11 | $206.80 | $2,275 | 3,864 | — | late |
| Jul 22, 2026 AForm 4 → | Jul 27, 4:34 pm EDT | Vicky B GreggDirector | 72 | $206.81 | $14,890 | 18,386 | — | late |
| Jul 22, 2026 LForm 4 → | Jul 27, 4:34 pm EDT | Patrick PlewmanSVP for Diagnostic Services | 46 | $206.81 | $9,513 | 15,293 | — | late |
| Jul 22, 2026 LForm 4 → | Jul 27, 4:33 pm EDT | Timothy L MainDirector | 21 | $206.81 | $4,343 | 22,460 | — | late |
| Jul 22, 2026 AForm 4 → | Jul 27, 4:33 pm EDT | Sam SamadExecutive Vice President & CFO | 102 | $206.81 | $21,094 | 33,478 | — | late |
| Jul 22, 2026 LForm 4 → | Jul 27, 4:33 pm EDT | Wright Lassiter IIIDirector | 6 | $206.81 | $1,241 | 10,323 | — | late |
| Jul 22, 2026 LForm 4 → | Jul 27, 4:32 pm EDT | Mark E DelaneySVP & Chief Commercial Officer | 34 | $206.81 | $7,031 | 11,935 | — | late |
| Jun 4, 2026 SForm 4 → | Jun 8, 4:32 pm EDT | Karthik KuppusamySVP, Clinical Solutions | 8,147 | $200.00 | $1,629,400 | 13,510 | −37.6% | 10b5-1 |
| Jun 4, 2026 MForm 4 → | Jun 8, 4:32 pm EDT | Karthik KuppusamySVP, Clinical Solutions | 8,147 | $124.22 | $1,012,000 | 21,657 | — | 10b5-1 |
| Mar 4, 2019 SForm 4 → | Mar 5, 4:32 pm EST | Michael E PrevoznikSVP & General Counsel | 3,373 | $86.81 | $292,810 | 39,458 | −7.88% | plan? |
| Mar 4, 2019 SForm 4 → | Mar 5, 4:26 pm EST | Everett CunninghamSVP, Commercial | 3,892 | $86.81 | $337,865 | 38,311 | −9.22% | plan? |
| Mar 1, 2019 AFForm 4 → | Mar 5, 4:34 pm EST | Stephen H RusckowskiChairman, President and CEO, Director | 61,039 | $86.86 | $5,301,848 | 213,049 | — | plan? |
| Mar 1, 2019 AFForm 4 → | Mar 5, 4:32 pm EST | Michael E PrevoznikSVP & General Counsel | 9,921 | $86.86 | $861,738 | 42,826 | — | plan? |
| Mar 1, 2019 AFForm 4 → | Mar 5, 4:31 pm EST | Robert A KlugVP, Corporate Controller | 1,775 | $86.86 | $154,177 | 6,261 | — | plan? |
| Mar 1, 2019 AFForm 4 → | Mar 5, 4:30 pm EST | Mark GuinanExecutive Vice President & CFO | 16,024 | $86.86 | $1,391,845 | 66,017 | — | plan? |
| Mar 1, 2019 AFForm 4 → | Mar 5, 4:29 pm EST | Catherine T. DohertySVP, Group Exec. Clin. Fran. | 11,446 | $86.86 | $994,200 | 73,416 | — | plan? |
| Mar 1, 2019 AFForm 4 → | Mar 5, 4:27 pm EST | J. E. DavisEVP, General Diagnostics | 16,064 | $86.86 | $1,395,319 | 44,534 | — | plan? |
| Mar 1, 2019 AFForm 4 → | Mar 5, 4:26 pm EST | Everett CunninghamSVP, Commercial | 11,446 | $86.86 | $994,200 | 42,151 | — | plan? |
| Feb 26, 2019 FForm 4 → | Feb 28, 5:32 pm EST | Stephen H RusckowskiChairman, President and CEO, Director | 6,676 | $87.84 | $586,420 | 197,406 | — | plan? |
| Feb 26, 2019 SForm 4 → | Feb 28, 5:24 pm EST | Michael E PrevoznikSVP & General Counsel | 1,412 | $86.65 | $122,352 | 39,453 | −3.46% | plan? |
| Feb 26, 2019 FForm 4 → | Feb 28, 5:24 pm EST | Michael E PrevoznikSVP & General Counsel | 907 | $87.84 | $79,671 | 40,865 | — | plan? |
| Feb 26, 2019 FForm 4 → | Feb 28, 5:22 pm EST | Robert A KlugVP, Corporate Controller | 142 | $87.84 | $12,473 | 5,293 | — | plan? |
| Feb 26, 2019 FForm 4 → | Feb 28, 5:21 pm EST | Mark GuinanExecutive Vice President & CFO | 1,556 | $87.84 | $136,679 | 60,569 | — | plan? |
| Feb 26, 2019 FForm 4 → | Feb 28, 5:19 pm EST | Catherine T. DohertySVP, Group Exec. Clin. Fran. | 1,066 | $87.84 | $93,637 | 69,524 | — | plan? |
| Feb 26, 2019 FForm 4 → | Feb 28, 5:15 pm EST | J. E. DavisEVP, General Diagnostics | 1,432 | $87.84 | $125,787 | 40,096 | — | plan? |
| Feb 26, 2019 SForm 4 → | Feb 28, 5:11 pm EST | Everett CunninghamSVP, Commercial | 1,496 | $86.64 | $129,613 | 38,259 | −3.76% | plan? |
| Feb 26, 2019 FForm 4 → | Feb 28, 5:11 pm EST | Everett CunninghamSVP, Commercial | 1,112 | $87.84 | $97,678 | 39,755 | — | plan? |
| Feb 25, 2019 FForm 4 → | Feb 27, 6:35 pm EST | Stephen H RusckowskiChairman, President and CEO, Director | 2,318 | $88.24 | $204,540 | 204,082 | — | plan? |
| Feb 25, 2019 SForm 4 → | Feb 27, 6:34 pm EST | Michael E PrevoznikSVP & General Counsel | 336 | $88.23 | $29,645 | 41,772 | −0.80% | plan? |
| Feb 25, 2019 FForm 4 → | Feb 27, 6:34 pm EST | Michael E PrevoznikSVP & General Counsel | 315 | $88.24 | $27,796 | 42,108 | — | plan? |
| Feb 25, 2019 FForm 4 → | Feb 27, 6:32 pm EST | Robert A KlugVP, Corporate Controller | 52 | $88.24 | $4,588 | 5,435 | — | plan? |
| Feb 25, 2019 FForm 4 → | Feb 27, 6:29 pm EST | Mark GuinanExecutive Vice President & CFO | 660 | $88.24 | $58,238 | 62,125 | — | plan? |
| Feb 25, 2019 FForm 4 → | Feb 27, 6:27 pm EST | Manner Carrie EglintonSVP, Advanced Diagnostics | 363 | $88.24 | $32,031 | 22,793 | — | plan? |
| Feb 25, 2019 FForm 4 → | Feb 27, 6:25 pm EST | Catherine T. DohertySVP, Group Exec. Clin. Fran. | 363 | $88.24 | $32,031 | 70,590 | — | plan? |
| Feb 25, 2019 FForm 4 → | Feb 27, 6:22 pm EST | J. E. DavisEVP, General Diagnostics | 547 | $88.24 | $48,267 | 41,528 | — | plan? |
| Feb 25, 2019 SForm 4 → | Feb 27, 6:19 pm EST | Everett CunninghamSVP, Commercial | 326 | $88.23 | $28,763 | 40,867 | −0.79% | plan? |
| Feb 25, 2019 FForm 4 → | Feb 27, 6:19 pm EST | Everett CunninghamSVP, Commercial | 431 | $88.24 | $38,031 | 41,193 | — | plan? |
| Feb 22, 2019 SForm 4 → | Feb 25, 8:08 pm EST | Gail R WilenskyDirector | 8,000 | $87.78 | $702,216 | 26,604 | −23.1% | plan? |
| Feb 22, 2019 MForm 4 → | Feb 25, 8:08 pm EST | Gail R WilenskyDirector | 8,000 | $51.55 | $412,400 | 34,604 | — | plan? |
| Feb 22, 2019 FForm 4 → | Feb 25, 8:06 pm EST | Robert A KlugVP, Corporate Controller | 50 | $88.39 | $4,420 | 5,487 | — | plan? |
| Feb 22, 2019 FForm 4 → | Feb 25, 8:04 pm EST | Stephen H RusckowskiChairman, President and CEO, Director | 2,215 | $88.39 | $195,784 | 206,400 | — | plan? |
| Feb 22, 2019 FForm 4 → | Feb 25, 8:01 pm EST | Michael E PrevoznikSVP & General Counsel | 291 | $88.39 | $25,721 | 42,423 | — | plan? |
| Feb 22, 2019 FForm 4 → | Feb 25, 7:58 pm EST | Mark GuinanExecutive Vice President & CFO | 610 | $88.39 | $53,918 | 62,785 | — | plan? |
| Feb 22, 2019 FForm 4 → | Feb 25, 7:55 pm EST | Manner Carrie EglintonSVP, Advanced Diagnostics | 392 | $88.39 | $34,649 | 23,156 | — | plan? |
| Feb 22, 2019 FForm 4 → | Feb 25, 7:53 pm EST | Catherine T. DohertySVP, Group Exec. Clin. Fran. | 336 | $88.39 | $29,699 | 70,953 | — | plan? |
| Feb 22, 2019 FForm 4 → | Feb 25, 7:40 pm EST | J. E. DavisEVP, General Diagnostics | 506 | $88.39 | $44,725 | 42,075 | — | plan? |
| Feb 22, 2019 FForm 4 → | Feb 25, 7:36 pm EST | Everett CunninghamSVP, Commercial | 398 | $88.39 | $35,179 | 41,624 | — | plan? |
| Feb 18, 2019 AForm 4 → | Feb 20, 6:44 pm EST | Denise M MorrisonDirector | 484 | — | — | 484 | — | plan? |
| Feb 18, 2019 AForm 4 → | Feb 20, 6:33 pm EST | Stephen H RusckowskiChairman, President and CEO, Director | 17,546 | — | — | 208,615 | — | plan? |
| Feb 18, 2019 AForm 4 → | Feb 20, 6:32 pm EST | Robert A KlugVP, Corporate Controller | 347 | — | — | 5,537 | — | plan? |
| Feb 18, 2019 AForm 4 → | Feb 20, 6:30 pm EST | Michael E PrevoznikSVP & General Counsel | 2,886 | — | — | 42,714 | — | plan? |
| Feb 18, 2019 AForm 4 → | Feb 20, 6:28 pm EST | Manner Carrie EglintonSVP, Advanced Diagnostics | 4,041 | — | — | 23,548 | — | plan? |
| Feb 18, 2019 AForm 4 → | Feb 20, 6:26 pm EST | Mark GuinanExecutive Vice President & CFO | 5,195 | — | — | 63,395 | — | plan? |
| Feb 18, 2019 AForm 4 → | Feb 20, 6:20 pm EST | Catherine T. DohertySVP, Group Exec. Clin. Fran. | 3,348 | — | — | 71,289 | — | plan? |
| Feb 18, 2019 AForm 4 → | Feb 20, 6:17 pm EST | J. E. DavisEVP, General Diagnostics | 4,964 | — | — | 42,581 | — | plan? |
| Feb 18, 2019 AForm 4 → | Feb 20, 6:13 pm EST | Everett CunninghamSVP, Commercial | 3,348 | — | — | 42,022 | — | plan? |
| Dec 31, 2018 FForm 4 → | Jan 3, 2019, 4:36 pm EST | Manner Carrie EglintonSVP, Advanced Diagnostics | 1,767 | $82.27 | $145,371 | 19,507 | — | plan? |
| Oct 12, 2018 FForm 4 → | Oct 16, 4:33 pm EDT | Robert A KlugVP, Corporate Controller | 8 | $100.51 | $804 | 4,972 | — | plan? |
| Aug 17, 2018 FForm 4 → | Aug 21, 4:32 pm EDT | Robert A KlugVP, Corporate Controller | 21 | — | — | 4,928 | — | plan? |
| Jul 10, 2018 SForm 4 → | Jul 12, 4:53 pm EDT | Michael E PrevoznikSVP & General Counsel | 30,780 | $113.07 | $3,480,141 | 39,791 | −43.6% | plan? |
| Jul 10, 2018 MForm 4 → | Jul 12, 4:53 pm EDT | Michael E PrevoznikSVP & General Counsel | 30,780 | $57.61 | $1,773,082 | 70,551 | — | plan? |
| Jul 10, 2018 SForm 4 → | Jul 12, 4:52 pm EDT | Everett CunninghamSVP, Commercial | 40,328 | $112.00 | $4,516,736 | 38,261 | −51.3% | plan? |
| Jul 10, 2018 MForm 4 → | Jul 12, 4:52 pm EDT | Everett CunninghamSVP, Commercial | 40,328 | $71.17 | $2,870,144 | 78,589 | — | plan? |
| Jul 2, 2018 SForm 4 → | Jul 5, 4:38 pm EDT | Everett CunninghamSVP, Commercial | 68,069 | $109.67 | $7,465,043 | 38,261 | −64.0% | plan? |
| Jul 2, 2018 MForm 4 → | Jul 5, 4:38 pm EDT | Everett CunninghamSVP, Commercial | 60,222 | $61.44 | $3,699,903 | 84,844 | — | plan? |
| Jun 4, 2018 GForm 4 → | Jun 6, 5:12 pm EDT | Jenne K BritellDirector | 8,704 | — | — | 14,479 | — | plan? |
| May 29, 2018 SForm 4 → | May 30, 4:38 pm EDT | Jeffrey M LeidenDirector | 1,644 | $105.61 | $173,623 | 6,000 | −21.5% | plan? |
| May 25, 2018 SForm 4 → | May 29, 4:39 pm EDT | Stephen H RusckowskiChairman, President and CEO, Director | 168,490 | $107.00 | $18,028,430 | 191,069 | −46.9% | plan? |
| May 25, 2018 MForm 4 → | May 29, 4:39 pm EDT | Stephen H RusckowskiChairman, President and CEO, Director | 168,490 | $56.12 | $9,455,659 | 359,559 | — | plan? |
| May 25, 2018 SForm 4 → | May 29, 4:37 pm EDT | Mark GuinanExecutive Vice President & CFO | 61,533 | $105.71 | $6,504,682 | 58,200 | −51.4% | plan? |
| May 25, 2018 MForm 4 → | May 29, 4:37 pm EDT | Mark GuinanExecutive Vice President & CFO | 61,533 | $58.37 | $3,591,374 | 119,733 | — | plan? |
| May 15, 2018 AForm 4 → | May 17, 5:43 pm EDT | Helen TorleyDirector | 1,644 | — | — | 1,644 | — | plan? |
| May 15, 2018 AForm 4 → | May 17, 5:40 pm EDT | Gail R WilenskyDirector | 1,644 | — | — | 26,604 | — | plan? |
| May 15, 2018 AForm 4 → | May 17, 5:35 pm EDT | Daniel StanzioneDirector | 1,644 | — | — | 36,319 | — | plan? |
| May 15, 2018 AForm 4 → | May 17, 5:32 pm EDT | Timothy M RingDirector | 1,644 | — | — | 16,496 | — | plan? |
| May 15, 2018 AForm 4 → | May 17, 5:29 pm EDT | Gary M PfeifferDirector | 1,644 | — | — | 17,462 | — | plan? |
| May 15, 2018 AForm 4 → | May 17, 5:25 pm EDT | Timothy L MainDirector | 1,644 | — | — | 16,335 | — | plan? |
| May 15, 2018 AForm 4 → | May 17, 5:22 pm EDT | Jeffrey M LeidenDirector | 1,644 | — | — | 7,644 | — | plan? |
| May 15, 2018 AForm 4 → | May 17, 5:09 pm EDT | Vicky B GreggDirector | 1,644 | — | — | 10,213 | — | plan? |
| May 15, 2018 AForm 4 → | May 17, 5:01 pm EDT | Jenne K BritellDirector | 1,644 | — | — | 23,183 | — | plan? |
| Mar 8, 2018 SForm 4 → | Mar 12, 4:33 pm EDT | Jon R CohenSVP & Group Exec. Diag. Sol. | 83,669 | $104.20 | $8,717,937 | 31,757 | −72.5% | plan? |
| Mar 8, 2018 MForm 4 → | Mar 12, 4:33 pm EDT | Jon R CohenSVP & Group Exec. Diag. Sol. | 38,928 | $66.51 | $2,589,101 | 115,426 | — | plan? |
| Mar 5, 2018 SForm 4 → | Mar 6, 7:41 pm EST | Michael E PrevoznikSVP & General Counsel | 4,128 | $101.00 | $416,928 | 39,771 | −9.40% | plan? |
| Mar 5, 2018 SForm 4 → | Mar 6, 7:39 pm EST | J. E. DavisEVP, General Diagnostics | 5,122 | $101.00 | $517,322 | 37,067 | −12.1% | plan? |
| Mar 5, 2018 SForm 4 → | Mar 6, 7:36 pm EST | Catherine T. DohertySVP, Group Exec. Clin. Fran. | 5,556 | $101.00 | $561,156 | 67,941 | −7.56% | plan? |
| Mar 2, 2018 AFForm 4 → | Mar 6, 7:52 pm EST | Mark GuinanExecutive Vice President & CFO | 19,608 | $101.00 | $1,980,408 | 58,200 | — | plan? |
| Mar 2, 2018 AFForm 4 → | Mar 6, 7:43 pm EST | Stephen H RusckowskiChairman, President and CEO, Director | 67,217 | $101.00 | $6,788,917 | 191,069 | — | plan? |
| Mar 2, 2018 AFForm 4 → | Mar 6, 7:41 pm EST | Michael E PrevoznikSVP & General Counsel | 12,140 | $101.00 | $1,226,140 | 43,899 | — | plan? |
| Mar 2, 2018 AFForm 4 → | Mar 6, 7:40 pm EST | Robert A KlugVP, Corporate Controller | 1,794 | $101.00 | $181,194 | 4,803 | — | plan? |
| Mar 2, 2018 AFForm 4 → | Mar 6, 7:39 pm EST | J. E. DavisEVP, General Diagnostics | 18,650 | $101.00 | $1,883,650 | 42,189 | — | plan? |
| Mar 2, 2018 ADForm 4 → | Mar 6, 7:38 pm EST | Everett CunninghamSVP, Commercial | 16,342 | $101.00 | $1,650,542 | 45,916 | — | plan? |
| Mar 2, 2018 AFForm 4 → | Mar 6, 7:37 pm EST | Jon R CohenSVP & Group Exec. Diag. Sol. | 16,342 | $101.00 | $1,650,542 | 76,498 | — | plan? |
| Mar 2, 2018 AFForm 4 → | Mar 6, 7:36 pm EST | Catherine T. DohertySVP, Group Exec. Clin. Fran. | 16,342 | $101.00 | $1,650,542 | 73,497 | — | plan? |
| Feb 27, 2018 FForm 4/A → | Mar 6, 7:47 pm EST | Mark GuinanExecutive Vice President & CFO | 779 | $101.43 | $79,014 | 51,534 | — | plan? |
| Feb 27, 2018 FForm 4 → | Mar 1, 5:11 pm EST | Stephen H RusckowskiChairman, President and CEO, Director | 3,017 | $101.43 | $306,014 | 170,708 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 28, 2026 MForm 4 → | Aug 31, 4:37 pm EDT | Michael E PrevoznikSVP & General Counsel | 22,677 | $112.17 | $2,543,679 | 0 | — | 10b5-1 |
| Jul 1, 2026 AForm 4 → | Jul 2, 4:34 pm EDT | Timothy C WentworthDirector | 144 | — | — | 342 | — | |
| Jun 4, 2026 MForm 4 → | Jun 8, 4:32 pm EDT | Karthik KuppusamySVP, Clinical Solutions | 8,147 | $124.22 | $1,012,000 | 0 | — | 10b5-1 |
| Feb 22, 2019 MForm 4 → | Feb 25, 8:08 pm EST | Gail R WilenskyDirector | 8,000 | $51.55 | $412,400 | 0 | — | |
| Feb 18, 2019 AForm 4 → | Feb 20, 6:44 pm EST | Denise M MorrisonDirector | 163 | $86.63 | $14,121 | 163 | — | |
| Feb 18, 2019 AForm 4 → | Feb 20, 6:33 pm EST | Stephen H RusckowskiChairman, President and CEO, Director | 213,704 | — | — | 213,704 | — | |
| Feb 18, 2019 AForm 4 → | Feb 20, 6:32 pm EST | Robert A KlugVP, Corporate Controller | 4,212 | — | — | 4,212 | — | |
| Feb 18, 2019 AForm 4 → | Feb 20, 6:30 pm EST | Michael E PrevoznikSVP & General Counsel | 35,146 | — | — | 35,146 | — | |
| Feb 18, 2019 AForm 4 → | Feb 20, 6:28 pm EST | Manner Carrie EglintonSVP, Advanced Diagnostics | 49,200 | — | — | 49,200 | — | |
| Feb 18, 2019 AForm 4 → | Feb 20, 6:26 pm EST | Mark GuinanExecutive Vice President & CFO | 63,259 | — | — | 63,259 | — | |
| Feb 18, 2019 AForm 4 → | Feb 20, 6:20 pm EST | Catherine T. DohertySVP, Group Exec. Clin. Fran. | 40,765 | — | — | 40,765 | — | |
| Feb 18, 2019 AForm 4 → | Feb 20, 6:17 pm EST | J. E. DavisEVP, General Diagnostics | 60,450 | — | — | 60,450 | — | |
| Feb 18, 2019 AForm 4 → | Feb 20, 6:13 pm EST | Everett CunninghamSVP, Commercial | 40,765 | — | — | 40,765 | — | |
| Jan 2, 2019 AForm 4 → | Jan 3, 4:37 pm EST | Timothy M RingDirector | 376 | $82.00 | $30,830 | 7,585 | — | |
| Oct 1, 2018 AForm 4 → | Oct 3, 6:53 pm EDT | Helen TorleyDirector | 1,298 | — | — | 1,298 | — | |
| Oct 1, 2018 AForm 4 → | Oct 3, 6:48 pm EDT | Timothy M RingDirector | 284 | $108.35 | $30,770 | 7,174 | — | |
| Jul 10, 2018 MForm 4 → | Jul 12, 4:53 pm EDT | Michael E PrevoznikSVP & General Counsel | 30,780 | $57.61 | $1,773,082 | 0 | — | |
| Jul 10, 2018 MForm 4 → | Jul 12, 4:52 pm EDT | Everett CunninghamSVP, Commercial | 40,328 | $71.17 | $2,870,144 | 0 | — | |
| Jul 2, 2018 MForm 4 → | Jul 5, 4:38 pm EDT | Everett CunninghamSVP, Commercial | 60,222 | $61.44 | $3,699,903 | 19,464 | — | |
| Jul 2, 2018 AForm 4 → | Jul 5, 4:35 pm EDT | Helen TorleyDirector | 1,297 | — | — | 1,297 | — | |
| Jul 2, 2018 AForm 4 → | Jul 5, 4:28 pm EDT | Timothy M RingDirector | 282 | $109.51 | $30,882 | 6,860 | — | |
| Jun 1, 2018 AForm 4 → | Jun 5, 4:55 pm EDT | Helen TorleyDirector | 665 | — | — | 665 | — | |
| May 25, 2018 MForm 4 → | May 29, 4:39 pm EDT | Stephen H RusckowskiChairman, President and CEO, Director | 168,490 | $56.12 | $9,455,659 | 0 | — | |
| May 25, 2018 MForm 4 → | May 29, 4:37 pm EDT | Mark GuinanExecutive Vice President & CFO | 61,533 | $58.37 | $3,591,374 | 0 | — | |
| Apr 2, 2018 AForm 4 → | Apr 4, 4:35 pm EDT | Timothy M RingDirector | 313 | $98.54 | $30,843 | 6,546 | — | |
| Mar 8, 2018 MForm 4 → | Mar 12, 4:33 pm EDT | Jon R CohenSVP & Group Exec. Diag. Sol. | 38,928 | $66.51 | $2,589,101 | 19,464 | — | |
| Feb 19, 2018 AForm 4 → | Feb 21, 7:39 pm EST | Mark GuinanExecutive Vice President & CFO | 50,764 | — | — | 50,764 | — | |
| Feb 19, 2018 AForm 4 → | Feb 21, 7:37 pm EST | Robert A KlugVP, Corporate Controller | 6,176 | — | — | 6,176 | — | |
| Feb 19, 2018 AForm 4 → | Feb 21, 7:34 pm EST | J. E. DavisEVP, General Diagnostics | 48,555 | — | — | 48,555 | — | |
| Feb 19, 2018 AForm 4 → | Feb 21, 7:32 pm EST | Everett CunninghamSVP, Commercial | 33,103 | — | — | 33,103 | — | |
| Feb 19, 2018 AForm 4 → | Feb 21, 7:31 pm EST | Jon R CohenSVP & Group Exec. Diag. Sol. | 27,589 | — | — | 27,589 | — | |
| Feb 19, 2018 AForm 4 → | Feb 21, 7:30 pm EST | Stephen H RusckowskiChairman, President and CEO, Director | 171,061 | — | — | 171,061 | — | |
| Feb 19, 2018 AForm 4 → | Feb 21, 7:26 pm EST | Michael E PrevoznikSVP & General Counsel | 28,690 | — | — | 28,690 | — | |
| Feb 19, 2018 AForm 4 → | Feb 21, 7:23 pm EST | Catherine T. DohertySVP, Group Exec. Clin. Fran. | 33,103 | — | — | 33,103 | — | |
| Feb 19, 2018 AForm 4 → | Feb 21, 7:19 pm EST | Manner Carrie EglintonSVP, Advanced Diagnostics | 38,623 | — | — | 38,623 | — | |
| Jan 29, 2018 MForm 4 → | Jan 31, 4:33 pm EST | Stephen H RusckowskiChairman, President and CEO, Director | 106,840 | $58.18 | $6,215,417 | 0 | — | |
| Jan 24, 2018 MForm 4 → | Jan 26, 4:43 pm EST | Catherine T. DohertySVP, Group Exec. Clin. Fran. | 21,294 | $52.17 | $1,110,802 | 0 | — | |
| Jan 2, 2018 AForm 4 → | Jan 4, 4:35 pm EST | Timothy M RingDirector | 312 | $98.73 | $30,802 | 6,206 | — | |
| Jan 2, 2018 MForm 4 → | Jan 4, 4:34 pm EST | J. E. DavisEVP, General Diagnostics | 63,880 | $52.17 | $3,332,300 | 0 | — | |
| Oct 2, 2017 AForm 4 → | Oct 4, 5:02 pm EDT | Timothy M RingDirector | 330 | $93.52 | $30,862 | 5,867 | — | |
| Sep 11, 2017 MForm 4 → | Sep 13, 6:20 pm EDT | Daniel StanzioneDirector | 40,900 | $57.15 | $2,337,327 | 0 | — | |
| Sep 11, 2017 MForm 4 → | Sep 13, 6:18 pm EDT | Stephen H RusckowskiChairman, President and CEO, Director | 59,235 | $58.18 | $3,445,996 | 106,840 | — | |
| Sep 5, 2017 MForm 4 → | Sep 7, 4:43 pm EDT | Daniel StanzioneDirector | 3,803 | $57.14 | $217,303 | 5,221 | — | |
| Sep 5, 2017 MForm 4 → | Sep 7, 4:40 pm EDT | Stephen H RusckowskiChairman, President and CEO, Director | 2,525 | $58.18 | $146,892 | 166,075 | — | |
| Jul 3, 2017 AForm 4 → | Jul 5, 4:35 pm EDT | Timothy M RingDirector | 276 | $111.81 | $30,860 | 5,516 | — | |
| Jun 19, 2017 MForm 4 → | Jun 21, 4:28 pm EDT | Jon R CohenSVP & Group Exec. Diag. Sol. | 106,900 | $53.95 | $5,766,897 | 0 | — | |
| Jun 19, 2017 MForm 4 → | Jun 21, 4:27 pm EDT | Catherine T. DohertySVP, Group Exec. Clin. Fran. | 59,762 | $57.40 | $3,430,413 | 0 | — | |
| Apr 24, 2017 MForm 4 → | Apr 26, 4:34 pm EDT | Jenne K BritellDirector | 6,111 | $57.67 | $352,421 | 0 | — | |
| Apr 20, 2017 MForm 4 → | Apr 24, 4:18 pm EDT | Michael E PrevoznikSVP & General Counsel | 29,513 | $56.78 | $1,675,743 | 0 | — | |
| Apr 3, 2017 AForm 4 → | Apr 5, 4:53 pm EDT | Timothy M RingDirector | 315 | $97.62 | $30,750 | 5,216 | — | |
| Mar 16, 2017 MForm 4 → | Mar 20, 4:37 pm EDT | Michael E PrevoznikSVP & General Counsel | 13,987 | $55.65 | $778,377 | 1,013 | — | |
| Feb 21, 2017 AForm 4 → | Feb 23, 6:17 pm EST | Stephen H RusckowskiChairman, President and CEO, Director | 187,845 | — | — | 187,845 | — | |
| Feb 21, 2017 AForm 4 → | Feb 23, 6:16 pm EST | Michael E PrevoznikSVP & General Counsel | 32,551 | $95.80 | $3,118,223 | 32,551 | — | |
| Feb 21, 2017 AForm 4 → | Feb 23, 6:15 pm EST | Robert A KlugVP, Corporate Controller | 6,758 | — | — | 6,758 | — | |
| Feb 21, 2017 AForm 4 → | Feb 23, 6:14 pm EST | Mark GuinanExecutive Vice President & CFO | 57,606 | — | — | 57,606 | — | |
| Feb 21, 2017 AForm 4 → | Feb 23, 6:13 pm EST | Manner Carrie EglintonSVP, Advanced Diagnostics | 37,565 | — | — | 37,565 | — | |
| Feb 21, 2017 AForm 4 → | Feb 23, 6:13 pm EST | Catherine T. DohertySVP, Group Exec. Clin. Fran. | 37,565 | $95.80 | $3,598,539 | 37,565 | — | |
| Feb 21, 2017 AForm 4 → | Feb 23, 6:12 pm EST | J. E. DavisEVP, General Diagnostics | 55,093 | — | — | 55,093 | — | |
| Feb 21, 2017 AForm 4 → | Feb 23, 6:11 pm EST | Jon R CohenSVP & Group Exec. Diag. Sol. | 37,565 | — | — | 37,565 | — | |
| Feb 21, 2017 AForm 4 → | Feb 23, 6:10 pm EST | Everett CunninghamSVP, Commercial | 37,565 | $95.80 | $3,598,539 | 37,565 | — | |
| Feb 2, 2017 MForm 4 → | Feb 6, 4:36 pm EST | Michael E PrevoznikSVP & General Counsel | 45,000 | $52.68 | $2,370,750 | 15,000 | — | |
| Jan 30, 2017 MForm 4 → | Feb 1, 8:23 pm EST | Catherine T. DohertySVP, Clin. Franchise Solutions | 80,000 | $54.01 | $4,321,172 | 6,595 | — | |
| Jan 3, 2017 AForm 4 → | Jan 5, 4:45 pm EST | Timothy M RingDirector | 333 | $93.07 | $30,992 | 4,878 | — | |
| Nov 15, 2016 MForm 4 → | Nov 17, 5:25 pm EST | Gary M PfeifferDirector | 34,333 | — | — | 0 | — | |
| Oct 3, 2016 AForm 4 → | Oct 5, 4:54 pm EDT | Timothy M RingDirector | 367 | $83.69 | $30,714 | 4,523 | — | |
| Aug 19, 2016 MForm 4 → | Aug 22, 4:53 pm EDT | Jenne K BritellDirector | 4,000 | $55.76 | $223,040 | 0 | — | |
| Aug 10, 2016 MForm 4 → | Aug 11, 4:32 pm EDT | Jenne K BritellDirector | 4,000 | $55.76 | $223,040 | 4,000 | — | |
| Aug 3, 2016 MForm 4 → | Aug 4, 4:46 pm EDT | Jeffrey M LeidenDirector | 6,641 | $69.52 | $461,696 | 0 | — | |
| Jul 1, 2016 AForm 4 → | Jul 5, 4:28 pm EDT | Timothy M RingDirector | 381 | $80.99 | $30,857 | 4,136 | — | |
| May 27, 2016 MForm 4 → | Jun 1, 4:39 pm EDT | Catherine T. DohertySVP, Clin. Franchise Solutions | 47,334 | $56.24 | $2,661,827 | 0 | — | |
| May 12, 2016 MForm 4 → | May 16, 4:25 pm EDT | Jenne K BritellDirector | 8,000 | $51.55 | $412,400 | 0 | — | |
| May 9, 2016 MForm 4 → | May 11, 4:21 pm EDT | Everett CunninghamSVP, Commercial | 56,312 | $59.66 | $3,359,672 | 40,328 | — | |
| May 6, 2016 MForm 4 → | May 9, 4:19 pm EDT | Everett CunninghamSVP, Commercial | 50,447 | $54.84 | $2,766,684 | 53,580 | — | |
| Apr 25, 2016 MForm 4 → | Apr 27, 4:19 pm EDT | Catherine T. DohertySVP, Clin. Franchise Solutions | 23,667 | $51.20 | $1,211,750 | 0 | — | |
| Apr 1, 2016 AForm 4 → | Apr 5, 5:11 pm EDT | Timothy M RingDirector | 430 | $72.07 | $30,990 | 3,735 | — | |
| Feb 25, 2016 AForm 4 → | Feb 29, 7:41 pm EST | Stephen H RusckowskiPresident and CEO, Director | 291,997 | — | — | 291,997 | — | |
| Feb 25, 2016 AForm 4 → | Feb 29, 7:40 pm EST | Michael E PrevoznikSVP & General Counsel | 50,604 | — | — | 50,604 | — | |
| Feb 25, 2016 AForm 4 → | Feb 29, 7:38 pm EST | Robert A KlugVP, Corporate Controller | 10,315 | — | — | 10,315 | — | |
| Feb 25, 2016 AForm 4 → | Feb 29, 7:37 pm EST | Mark GuinanSenior Vice President & CFO | 81,756 | — | — | 81,756 | — | |
| Feb 25, 2016 AForm 4 → | Feb 29, 7:36 pm EST | J. E. DavisSVP, Regional Businesses | 77,856 | — | — | 77,856 | — | |
| Feb 25, 2016 AForm 4 → | Feb 29, 7:35 pm EST | Catherine T. DohertySVP, Clin. Franchise Solutions | 58,392 | — | — | 58,392 | — | |
| Feb 25, 2016 AForm 4 → | Feb 29, 7:34 pm EST | Everett CunninghamSVP, Commercial | 58,392 | — | — | 58,392 | — | |
| Feb 25, 2016 AForm 4 → | Feb 29, 7:32 pm EST | Jon R CohenSVP, Diagnostic Solutions | 58,392 | — | — | 58,392 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 6:15 pm EST | Timothy M RingDirector | 577 | $70.37 | $40,603 | 3,223 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 6:13 pm EST | Jeffrey M LeidenDirector | 311 | — | — | 311 | — | |
| Oct 1, 2015 AForm 4 → | Oct 5, 4:33 pm EDT | Jeffrey M LeidenDirector | 1,747 | — | — | 1,747 | — | |
| Aug 17, 2015 AForm 4 → | Aug 19, 4:46 pm EDT | Robert A KlugVP, Corporate Controller | 1,435 | — | — | 1,435 | — | |
| Jul 1, 2015 AForm 4 → | Jul 2, 4:39 pm EDT | Jeffrey M LeidenDirector | 1,563 | — | — | 1,563 | — | |
| Apr 1, 2015 AForm 4 → | Apr 2, 4:32 pm EDT | Jeffrey M LeidenDirector | 1,518 | — | — | 1,518 | — | |
| Feb 23, 2015 AForm 4 → | Feb 25, 4:41 pm EST | Catherine T. DohertySVP, Physician Services Bus. | 60,492 | — | — | 60,492 | — | |
| Feb 23, 2015 AForm 4 → | Feb 25, 4:41 pm EST | Everett CunninghamSVP, Commercial | 60,492 | — | — | 60,492 | — | |
| Feb 23, 2015 AForm 4 → | Feb 25, 4:40 pm EST | Jon R CohenSVP and Chief Medical Officer | 60,492 | — | — | 60,492 | — | |
| Feb 23, 2015 AForm 4 → | Feb 25, 4:39 pm EST | Stephen H RusckowskiPresident and CEO, Director | 241,995 | — | — | 241,995 | — | |
| Feb 23, 2015 AForm 4 → | Feb 25, 4:38 pm EST | Mark GuinanSenior Vice President & CFO | 72,596 | — | — | 72,596 | — | |
| Feb 23, 2015 AForm 4 → | Feb 25, 4:38 pm EST | Michael E PrevoznikSVP & General Counsel | 44,939 | — | — | 44,939 | — | |
| Feb 23, 2015 AForm 4 → | Feb 25, 4:37 pm EST | J. E. DavisSVP, Operations | 65,681 | — | — | 65,681 | — | |
| Feb 11, 2015 MForm 4 → | Feb 12, 4:40 pm EST | Daniel StanzioneDirector | 8,000 | — | — | 0 | — | |
| Feb 4, 2015 MForm 4 → | Feb 5, 4:50 pm EST | Gary M PfeifferDirector | 8,000 | — | — | 0 | — | |
| Feb 4, 2015 MForm 4 → | Feb 5, 4:44 pm EST | Gail R WilenskyDirector | 8,000 | — | — | 0 | — | |
| Feb 3, 2015 MForm 4 → | Feb 4, 6:37 pm EST | John B ZieglerDirector | 8,000 | $51.55 | $412,400 | 0 | — |